ACMSD

gene product
The neuronal excitotoxin quinolinate is an intermediate in the de novo synthesis pathway of NAD from tryptophan, and has been implicated in the pathogenesis of several neurodegenerative disorders. Quinolinate is derived from alpha-amino-beta-carboxy-muconate-epsilon-semialdehyde (ACMS). ACMSD (ACMS decarboxylase; EC 4.1.1.45) can divert ACMS to a benign catabolite and thus prevent the accumulation of quinolinate from ACMS. [supplied by OMIM, Oct 2004]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
74 antibodies from 19 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Atlas Antibodies
2 antibodies
Biorbyt
3 antibodies
Novus Biologicals
4 antibodies
antibodies-online
15 antibodies
LifeSpan BioSciences, Inc.
23 antibodies
OriGene
4 antibodies
Abnova Corporation
3 antibodies
Aviva Systems Biology
2 antibodies
GeneTex
1 antibody
Invitrogen Antibodies
3 antibodies
Signalway Antibody LLC
1 antibody
Acris Antibodies GmbH
1 antibody
MyBioSource
3 antibodies
Boster Biological Technology
1 antibody
RabMAbs
1 antibody
Sigma-Aldrich
3 antibodies
Creative Diagnostics
2 antibodies
Creative Biolabs
1 antibody
United States Biological
1 antibody